Selenocarbamates with broad molecular diversity were synthesised and their inhibitory activities against human carbonic anhydrases (CAs) I, II, IX, and XII were investigated. The CA-mediated hydrolysis of selenocarbamates enables the release of selenolates, behaving as highly active zinc binding groups. X-ray co-crystallographic studies on such potential prodrugs for controlled CA inhibition were also
合成了具有广泛分子多样性的
硒代
氨基甲酸盐,并研究了它们对人
碳酸酐酶 (CAs) I、II、IX 和 XII 的抑制活性。CA 介导的
硒代
氨基甲酸酯
水解能够释放
硒醇盐,表现为高活性
锌结合基团。还对这些用于控制 CA 抑制的潜在前药进行了 X 射线共晶体学研究。